Sotagliflozin significantly reduces heart attacks and strokes in high-risk patients with diabetes and kidney disease, ...

The US recently approved clinical trials for pig kidney transplants, opening the door to the potential use of other organs ...

Novo Nordisk alleges Singaporean biotech KBP Biosciences made misleading statements before the two firms inked a licensing ...

The U.S. Food and Drug Administration (FDA) has granted fast track status to ADI-001, Adicet Bio ’s CAR T-cell therapy for ...

One of the scariest moments of my life happened in 2022 when my father, Tom Donvito, then 75 and unaware of any allergies, experienced an anaphylactic reaction to a hornet sting. After he passed ...

An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

Industry experts and providers are worried layoffs at the Health and Human Services Department could slow down prior ...

Chia seeds nutrition is impressive, offering antioxidants, fiber, protein and other beneficial nutrients. Learn more about ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Investigators compared the outcomes of patients with type 2 diabetes who continued versus stopped metformin after progressing to stage 4 chronic kidney disease.

Casdatifan’s progression-free survival benefits could help differentiate it from Merck’s Welireg in the kidney cancer arena, ...

The results showed that people who took sotagliflozin had a 23% lower risk of heart attacks, strokes, and death from ...